Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan J Miller

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Computers in Biology and Medicine|August 12, 2025
Post-processing of coronary and myocardial spatial dataJay A Mackenzie, Megan J Miller, Mette S Olufsen, et al.
Diseases of the Colon and Rectum|September 1, 2007
Rectoanal sensorimotor response in humans during rectal distensionSherrie De Ocampo, Jose M Remes-Troche, Megan J Miller, et al.
Oncoimmunology|November 22, 2012
Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivoKevin C Foy, Megan J Miller, Nicanor Moldovan, et al.
Oncoimmunology|March 13, 2013
Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. OncoImmunology 2012; 1:1048-1060Kevin C Foy, Megan J Miller, Nicanor Moldovan, et al.
Oncoimmunology|May 6, 2015
IGF-1R peptide vaccines/mimics inhibit the growth of BxPC3 and JIMT-1 cancer cells and exhibit synergistic antitumor effects with HER-1 and HER-2 peptidesKevin Chu Foy, Megan J Miller, Jay Overholser, et al.
Oncoimmunology|November 22, 2012
Immunotherapy with HER-2 and VEGF peptide mimics plus metronomic paclitaxel causes superior antineoplastic effects in transplantable and transgenic mouse models of human breast cancerKevin C Foy, Megan J Miller, Nicanor Moldovan, et al.
Journal of Psychosomatic Research|October 2, 2007
Psychological profiles and quality of life differ between patients with dyssynergia and those with slow transit constipationSatish S C Rao, Kara Seaton, Megan J Miller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 24, 2013
Peptide vaccines and peptidomimetics of EGFR (HER-1) ligand binding domain inhibit cancer cell growth in vitro and in vivoKevin Chu Foy, Ruthie M Wygle, Megan J Miller, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Computers in Biology and Medicine|August 12, 2025
Post-processing of coronary and myocardial spatial dataJay A Mackenzie, Megan J Miller, Mette S Olufsen, et al.
Diseases of the Colon and Rectum|September 1, 2007
Rectoanal sensorimotor response in humans during rectal distensionSherrie De Ocampo, Jose M Remes-Troche, Megan J Miller, et al.
Oncoimmunology|November 22, 2012
Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivoKevin C Foy, Megan J Miller, Nicanor Moldovan, et al.
Oncoimmunology|March 13, 2013
Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. OncoImmunology 2012; 1:1048-1060Kevin C Foy, Megan J Miller, Nicanor Moldovan, et al.
Oncoimmunology|May 6, 2015
IGF-1R peptide vaccines/mimics inhibit the growth of BxPC3 and JIMT-1 cancer cells and exhibit synergistic antitumor effects with HER-1 and HER-2 peptidesKevin Chu Foy, Megan J Miller, Jay Overholser, et al.
Oncoimmunology|November 22, 2012
Immunotherapy with HER-2 and VEGF peptide mimics plus metronomic paclitaxel causes superior antineoplastic effects in transplantable and transgenic mouse models of human breast cancerKevin C Foy, Megan J Miller, Nicanor Moldovan, et al.
Journal of Psychosomatic Research|October 2, 2007
Psychological profiles and quality of life differ between patients with dyssynergia and those with slow transit constipationSatish S C Rao, Kara Seaton, Megan J Miller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 24, 2013
Peptide vaccines and peptidomimetics of EGFR (HER-1) ligand binding domain inhibit cancer cell growth in vitro and in vivoKevin Chu Foy, Ruthie M Wygle, Megan J Miller, et al.
Pageof 1